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I Report of meeting of the Section of Clinical Immunology & Allergy, II May 1981
The detection of different Lyt alloantigens on functionally distinct mouse T lymphocyte subpopulations (Cantor & Boyse 1977) facilitated the classification of human T lymphocyte subsets with similar methods. First, heterologous antisera to human T cell subsets were made and, more recently, monoclonal antibodies have been found (Table 1) (Evans et al. 1978 , Reinherz &. Schlossman 1980 . At the meeting information on human thymocytes and T cell subsets was summarized and theoretical and clinical implications discussed. medullary thymocytes. In peripheral lymphoid organs, these cells of inducer type selectively represented the T cells within the germinal centres. The inducer type cells all tended to form close contracts with large la-like (HLA-DA) antigen positive macrophage-like cells (interdigitating cells in the paracortical area of nodes and gut macrophages in the lamina propria). In contrast, T cells of suppressor and cytotoxic type are the dominant cell of the human bone marrow and the gut epithelium (intra-epithelial lymphocytes). The physiological and pathological .significance of these findings are that they show that the T cell subsets characterized in functional assays in vitro have different tissue distribution and role in vivo. It is therefore now possible to analyse the regeneration of T cell subsets with both histology and functional assays after bone marrow transplantation, as well as in immunoregulatory disorders such as rheumatoid arthritis and in graft-versus-host disease.
Dr Melvyn Greaves of the Imperial Cancer Research Fund then described how he had characterized 72 consecutive cases of T cell malignancy (excluding non-T, non-B acute leukaemias) with the OKT series and other monoclonal antibodies . These results were correlated with the phenotypes of the corresponding normal cells in the thymus and peripheral organs. The comparisons revealed that all cases of T-acute lymphoblastic leukaemia as well as childhood T-type non-Hodgkin lymphoma had intrathymic phenotypes. Most of these cells, particularly in those' with T-ALL, had characteristics of early thymic precursor cells. In contrast, all cases ofT chronic lymphocytic and T prolymphocytic leukaemia and adult T lymphomas had the mature T cell phenotype. These results strongly suggest that these malignancies come from different intrathymic and peripheral T cell clones, respe~ti vel y.
The biological dilemma ofT-ALL cells being unable to 'mature' into peripheral T cell forms was also investigated. In common with other non-T leukaemia lines (e.g. HL-60, K562) some T-ALL cell lines can be 'induced' to acquire a mature phenotype when incubated in vitro with phorbol ester. Under these conditions T cells of suppressor/cytotoxic phenotype were induced -T8+, T4-or weak, T3+, TdT enzyme negative and strongly HLA-A, B, C positive (Delia & Greaves 1981 Dr George Janossy of the Royal Free Hospital reported his recent collaborative studies on the thymocyte differentiation and T subset distribution in peripheral lymphoid organs , Tidman et al. 1981 . 'The advantage of these antibodies is that they can be applied in both' tissue sections and suspensions in combination with each other or with heterologous antisera. He showed that a population of large thymic blasts (putative precursors) had some similarities to bone marrow' precursor cells. These cells reacted with OKT II but were essentially negative with the other T cell markers. The majority of the cortical thymocyte population expressed T4, T5, and T8, while T3, a peripheral T cell. marker and the dominantlyT4+, shown to be all functionally mature T cells. In some patients with neutropenia or red cell aplasia the majority of lymphocytes were UCHTl + but OKTI-. This was surprising as OKTI-like antisera have also been claimed to be markers for all peripheral T lymphocytes (Reinherz et al. 1980 . The UCHTl + but OKTl-T cells also form rosettes with sheep red cells (E rosettes) and carry the OKT8/Leu-2A antigens characteristic of the human suppressor/cytotoxic subset . They also have Fc receptors for IgG (FCyR). These Ty cells nevertheless lack the ability to suppress the pokeweed mitogen-induced synthesis of immunoglobulin. The role of the subset in the pathogenesis of neutropenia remains obscure but their expansion in this particular disease has now focused attention on this cell type. Small numbers of cells with this phenotype are found in normal individuals and, on the basis of analogous observations in the mouse, could be cytotoxic cells . The larger subset of suppressor/cytotoxic cells lack FcyR and are OKTl ". This subset expands in diseases such as infectious mononucleosis and is able to suppress immunoglobulin synthesis in pokeweed mitogen stimulated cultures.
The final talk on T subsets in Epstein-Barr virus related disorders was given by Dr Dorothy Crawford of the Royal Free Hospital (now at UCH). A few T cells in the blood of seropositive individuals are cytotoxic for autologous EB virus infected B cells in culture. These cytotoxic cells are OKT8 + (Leu2a "), Their activity is inhibited by cyc1osporin-A in vitro and in vivo (Bird et al. 1981 , Crawford, Sweny et al. 1981 and recently an EB virus genome-containing lymphoma has been diagnosed in a patient receiving this drug (Crawford et al. 1980) . The atypical T cells in the blood of patients with infectious mononucleosis are OKT8+, OKT4- (Crawford, Bricknell et al. 1981) but are functionally suppressor (Tosato et al. 1979) rather than cytotoxic cells (Rickinson et al. 1980) . Taken together, these findings suggest that the mechanisms controlling primary EB virus infection differ from the long-term immunity in seropositive individuals.
The basis of T cell taxonomy was reviewed. Since the monoclonal antibodies used are standard reagents, the techniques could be applied easily to a wide variety of clinical disorders. Some pathological changes in T cell populations were reported in infectious mononucleosis, haemopoietic and malignant conditions.
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